Heart Defects, Congenital Clinical Trial
— CHD-PALS V2Official title:
Establishing Efficacy for the Congenital Heart Disease Physical Activity Lifestyle Intervention
The Congenital Heart Disease Physical Activity Lifestyle Intervention Study (CHD-PALS) V.2 seeks to determine the efficacy of a lifestyle intervention program for adolescents and young adults (AYAs) with congenital heart disease (CHD). This trial was adapted from the original CHD-PAL trial to continue improving cardiovascular outcomes for transition-aged CHD survivors.
Status | Recruiting |
Enrollment | 144 |
Est. completion date | June 30, 2027 |
Est. primary completion date | April 1, 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 15 Years to 25 Years |
Eligibility | Inclusion Criteria: - Between the ages of 15-25 years - Diagnosed with moderate or complex structural CHD - Actively receiving care from a cardiologist at Nationwide Children's Hospital (NCH) or Ohio State University (OSU) Exclusion Criteria: - Unable to speak and read proficiently in English - Have a diagnosis of a genetic syndrome that impacts multiple organ systems - Have cognitive impairments that would interfere with completing study measures - Have been engaged in a formal exercise program within the past 6 months, - Have participated in the intervention arm of the previous CHD-PAL Study - Have undergone open-heart surgery or had a valve replacement in the last 3 months - Are unable to complete an exercise stress test using a treadmill - Are pregnant - Are prohibited to engage in at least moderate levels of physical activity by their cardiologist - Engage in >30 minutes of moderate-to-vigorous physical activity per day, on average per accelerometer - Have contraindications for exercise based on an exercise stress test (e.g., exercise-induced arrhythmias or evidence of cardiac ischemia) |
Country | Name | City | State |
---|---|---|---|
United States | Nationwide Children's Hospital | Columbus | Ohio |
Lead Sponsor | Collaborator |
---|---|
Jamie Jackson | National Institute of Nursing Research (NINR) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Cardiorespiratory Fitness-Volume of Oxygen Consumption (Peak VO2) | Peak VO2 is the highest value of oxygen consumption during an exercise stress test and is widely used as an indicator of cardiorespiratory fitness. Peak VO2 will be measured at baseline and post-intervention to examine the impact of CHD-PAL on change in biological markers of cardiovascular health. | Baseline to Week 20 | |
Other | Cardiorespiratory Fitness- Metabolic Equivalents (METs) | MET scores, or metabolic equivalents, represent the amount of oxygen consumed at rest or during activity. It is a simple, practical way to express the energy cost of different physical activities. METs, as assessed during the exercise stress test, will be measured at baseline and post-intervention to examine the impact of CHD-PAL on change in biological markers of cardiovascular health. METs are calculated by: ([miles per hour x 26.8 x 0.1] + [grade/100 x 1.8 x miles per hour x 26.8] + 3.5)/3.5 and the highest MET achieved during the stress test will be abstracted. | Baseline to Week 20 | |
Primary | Moderate to Vigorous Physical Activity (MVPA) | Number of minutes spent in moderate to vigorous physical activity as measured by an accelerometer. | Baseline to Weeks 20, 40, and 80 | |
Secondary | Physical Activity Enjoyment/Engagement Scale (Attitudes) | 18-item measure of enjoyment and dislike of physical activity in which the participant currently engages. Each item is rated on a 7-point Likert scale with a positive attitude (e.g., I enjoy it) and negative attitude (e.g., I hate it) towards physical activity on each end. | Baseline to Weeks 10, 20, 40, and 80 | |
Secondary | Affective Attitudes for Physical Activity Scale (Attitudes) | 4-item measure of affective physical activity attitudes using bipolar adjectives on a 7-point Likert scale (i.e., enjoyable-unenjoyable, boring-interesting, pleasant-unpleasant, stressful-relaxing). | Baseline to Weeks 10, 20, 40, and 80 | |
Secondary | Physical Activity Norms Measure (Social Norms) | 5-item measure of perceptions of subjective norms of physical activity (e.g. "Members of my family think I should be physically active regularly"). An additional item was added to assess norms of cardiologist. Original item wording of "during my free time on most days" was changed to "regularly." Participants are presented with a 5-point Likert scale ranging from "Strongly disagree" to "Strongly agree." One item ("Compared to others of your age and sex, mark how active you are.") is measured on a 5-point Likert scale ranging from "Much less active" to "Much more active." | Baseline to Weeks 10, 20, 40, and 80 | |
Secondary | Family and Partner Support for Physical Activity Engagement Measure (Social Norms) | 39-item measure asking participants to indicate "None," "Rarely," "A few times," Often," "Very often," and "Does not apply," when rating the extent to which family (i.e., parents, siblings) and friends provided support for physical activity in different contexts within the past 3 months. This measure has been modified to include items for partners. | Baseline to Weeks 10, 20, 40, and 80 | |
Secondary | Perceived Control for Physical Activity Engagement Measure (Perceived Control) | 5-item measure of perceived control for engaging in regular physical activity. Wording was adapted to use "physical activity" instead of "exercise". Each item is rated on a 7-point Likert scale with a negative perception of control (e.g., Very little control) and positive perception of control (e.g., Complete control) of physical activity engagement on each end. | Baseline to Weeks 10, 20, 40, and 80 | |
Secondary | Exercise Confidence Survey (Perceived Control) | 12-item questionnaire assessing health-related self-efficacy in adjusting physical activity behaviors. The original questionnaire has items for self-efficacy in diet behaviors, which have been removed for the purpose of this study. Wording has also been modified to reflect "physical activity"/"physically active" language. Items are measured on a 5-point Likert scale from "I know I cannot" to "I know I can" with an additional option of "Does not apply." | Baseline to Weeks 10, 20, 40, and 80 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05330338 -
Genetics of Ventriculo-arterial Discordance
|
N/A | |
Withdrawn |
NCT03405636 -
Xeltis Pulmonary Valved Conduit Safety and Performance Study
|
N/A | |
Completed |
NCT02443662 -
Colloid Osmotic Pressure in Patients With Fontan Circulation
|
||
Terminated |
NCT02519335 -
Use of the Cardioprotectant Dexrazoxane During Congenital Heart Surgery: Proposal for Pilot Investigation
|
Phase 1 | |
Completed |
NCT01835392 -
Neuroprotective Effects of Remote Ischemic Preconditioning (RIPC) During Infant Cardiac Surgery
|
N/A | |
Completed |
NCT00371891 -
Ontario Multidetector Computed Tomographic (MDCT) Coronary Angiography Study (OMCAS)
|
Phase 4 | |
Completed |
NCT03035552 -
CTICU Pacifier Activated Music Player and Mother's Voice
|
N/A | |
Recruiting |
NCT04581668 -
Impact of NAVA Ventilation on Brain Oxygenation and Perfusion in Children With Congenital Heart Disease
|
N/A | |
Enrolling by invitation |
NCT04866537 -
Evaluation of the Diagnostic Performance of Specialized Fetal Cardiac Ultrasound in the CPDPN - Arc Alpin Network
|
||
Completed |
NCT03049540 -
Effect of Phosphodiesterase-5 Inhibition With Tadalafil on SystEmic Right VEntricular Size and Function
|
Phase 3 | |
Completed |
NCT02377674 -
Safety and Performance of the COR-VG-001 Conduit in Pediatric Patients for Extracardiac Total Cavopulmonary Connection
|
N/A | |
Completed |
NCT01679275 -
Pre-operative Cerebral Oxygenation in Neonates With Congenital Heart Disease
|
||
Terminated |
NCT00543309 -
Effects of Perioperative Nesiritide or Milrinone Infusion on Recovery From Fontan Surgery
|
Phase 2 | |
Completed |
NCT03957512 -
Livet Skal Leves (A Life to Live)
|
||
Recruiting |
NCT06005428 -
Effectiveness of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
|
Phase 2 | |
Recruiting |
NCT02691689 -
Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions
|
N/A | |
Completed |
NCT02306057 -
Fluid Balance in Children Undergoing Fontan Surgery
|
N/A | |
Recruiting |
NCT02157597 -
NIRS Guidance Trail in Children's Heart Surgery
|
N/A | |
Completed |
NCT01570933 -
Feasibility Study Over the NAVA Mode in Noninvasive Ventilation After Cardiac Surgery in Infants.
|
Phase 4 | |
Completed |
NCT00396877 -
Efficacy And Safety Of Clopidogrel In Neonates /Infants With Systemic To Pulmonary Artery Shunt Palliation
|
Phase 3 |